NCT00984139 - Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination | Biotech Hunter

Enrollment

306

Participants

Timeline

Start Date

October 12, 2009

Primary Completion Date

April 7, 2010

Study Completion Date

April 7, 2010

Conditions

Hepatitis B

Interventions

BIOLOGICAL

Engerix™-B Kinder

Intramuscular, one dose.

Trial Locations (24)

10315

GSK Investigational Site, Berlin

10967

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

34225

GSK Investigational Site, Braunatal

47137

GSK Investigational Site, Duisburg

48163

GSK Investigational Site, Münster

67227

GSK Investigational Site, Frankenthal

67547

GSK Investigational Site, Worms

68163

GSK Investigational Site, Mannheim

70469

GSK Investigational Site, Stuttgart

74523

GSK Investigational Site, Schwäbisch Hall

75172

GSK Investigational Site, Pforzheim

77694

GSK Investigational Site, Kehl

77955

GSK Investigational Site, Ettenheim

78532

GSK Investigational Site, Tuttlingen

81375

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

82205

GSK Investigational Site, Gilching

85551

GSK Investigational Site, Kirchheim

86720

GSK Investigational Site, Nördlingen

87435

GSK Investigational Site, Kempten (Allgäu)

93413

GSK Investigational Site, Cham

95463

GSK Investigational Site, Bindlach

99425

GSK Investigational Site, Weimar